Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
about
Visual dysfunction in Parkinson's diseaseThe Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseThe prediagnostic phase of Parkinson's diseaseGlucocerebrosidase and Parkinson disease: Recent advancesThe relationship between glucocerebrosidase mutations and Parkinson diseaseMitochondrial dysfunction associated with glucocerebrosidase deficiencyNeuropsychiatric characteristics of GBA-associated Parkinson disease.Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.GBA mutations are associated with Rapid Eye Movement Sleep Behavior DisorderProgression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease.A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation AnalysisParkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.Biomarkers in Parkinson's disease: Advances and strategies.Transcriptomic Profiling of Egg Quality in Sea Bass (Dicentrarchus labrax) Sheds Light on Genes Involved in Ubiquitination and Translation.PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.A molecular analysis of the GBA gene in Caucasian South Africans with Parkinson's disease.The Concept of Prodromal Parkinson's Disease.Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment.New Directions in Gaucher Disease.The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.Non-motor features of Parkinson disease.Glucocerebrosidase Mutations in Parkinson Disease.Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.Trajectories of prediagnostic functioning in Parkinson's disease.Simple Test of Manual Dexterity Can Help to Identify Persons at High Risk for Neurodegenerative Diseases in the Community.Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease.Glucocerebrosidase expression patterns in the non-human primate brain.Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.Premotor Diagnosis of Parkinson's Disease.Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.Cognitive changes in prodromal Parkinson's disease: A review.Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?Tracking the course of prodromal Parkinson's disease.Self-report depressive symptoms are dissociated from tremor severity in essential tremor.GBA-associated parkinsonism and dementia: beyond α-synucleinopathies?A Meta-Analysis of -Related Clinical Symptoms in Parkinson's DiseaseRecent Advances in Biomarkers for Parkinson's Disease
P2860
Q26740467-6B678C76-882A-4C30-BB73-234555262FAFQ26744716-C5064B6C-0009-4A31-8CB5-62341D2E628FQ26768732-726265CE-72A3-475F-9383-2F312870F877Q27005669-2185D233-5C50-4C4F-A7F0-1F245733D487Q28077257-E24A70C3-3C61-4357-B2BF-B2C6C492E9EDQ28115678-B360E2D7-BE61-46BD-96C7-D7546FE42262Q30275630-67BC4AA0-E3B7-4940-8E52-247D14E1C730Q30367337-804B9818-44DB-428B-9DC9-C9AB6D8B3A71Q36072435-AA24312C-E488-4238-B060-C1C7EAB70F54Q36123828-DE396EB9-BE35-4E81-BB41-448020B6F679Q36885946-7C0CE074-5AB7-4BFF-B56E-7C494C1DA463Q37189019-C102CE0A-296D-4244-ABCE-520297904623Q37431507-7A50828F-3BB6-4C2C-9359-DDE804A4A44DQ37662740-D3CB43B1-CE1C-4DD5-99D0-959117E7D229Q37663889-6785DBA2-94F1-414F-BB0A-8FFBAA063F71Q37725826-39DB826F-3013-442A-85BA-9F16593CD9ADQ38612230-E1BD36F8-6500-4730-953B-D7B6538ABE62Q38811401-41B3FE21-D9A8-45F5-876B-F5381E05DFA2Q38905996-69543936-06F0-4034-9FDD-2CA2BC99F1FAQ39148146-16118BBF-6F00-4EDD-B4C1-CCC914046290Q39332667-65A72336-7042-4D8E-B6F7-3CBF8578C43DQ39358549-F26A5C36-2867-4BB9-9985-678C98EABAFAQ39362339-3291E203-67A1-4E28-BE0E-B569F2EBA29DQ40114382-C15E4795-BD2C-4F8D-A738-EC11E580A2ADQ40383022-1EC0BEAB-1A5D-4243-BED9-1F9D1BEA614DQ40670425-E860E8D0-CD64-40C9-B09D-DE3C02E79ADDQ41082517-F9932E8B-63D7-4652-A36D-06A3D2C912BAQ41652414-D8ED8AFF-E383-4D58-B9FC-C92F213E4AECQ42513965-9E52FD11-6D7A-4090-ABD3-0BEE4995771EQ47323174-5054ABD0-483A-4090-9159-6F2BF32CA733Q47701138-1476EB92-02FB-4B1C-B637-A3469F04F8A5Q47701585-5EAC655F-D3A4-4E40-A8A5-7DD65C7A71C4Q47860019-0F803522-8902-4313-954E-93B40315F852Q48129130-E7A89175-D2E9-4DE7-BCBF-2396E1417E6FQ48332639-C2356F69-F2B8-40FC-A59C-65E9694CF336Q51766077-740FAC65-0100-4DF4-BD3D-9EF637B68CD3Q52147014-F68C75D8-CE56-4A75-BA78-6B813430AF5EQ58549914-C9B1C971-6136-4932-A832-1DBF159045BDQ58572579-E22BEB20-C003-44B9-B099-913375B4DEBB
P2860
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evolution of prodromal clinica ...... GBA mutation-positive cohort.
@ast
Evolution of prodromal clinica ...... GBA mutation-positive cohort.
@en
type
label
Evolution of prodromal clinica ...... GBA mutation-positive cohort.
@ast
Evolution of prodromal clinica ...... GBA mutation-positive cohort.
@en
altLabel
Evolution of Prodromal Clinica ...... n aGBAMutation–Positive Cohort
@en
prefLabel
Evolution of prodromal clinica ...... GBA mutation-positive cohort.
@ast
Evolution of prodromal clinica ...... GBA mutation-positive cohort.
@en
P2093
P2860
P1433
P1476
Evolution of prodromal clinica ...... a GBA mutation-positive cohort
@en
P2093
Alisdair McNeill
Anthony H V Schapira
Atul Mehta
Michelle Beavan
P2860
P304
P356
10.1001/JAMANEUROL.2014.2950
P407
P577
2015-02-01T00:00:00Z